US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

240.14

+17.147.69%

Volume:363.50K

Turnover:85.57M

Market Cap:630.25M

PE:- -

High:242.94

Open:223.71

Low:222.88

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.71

T/O Rate:13.85%

Dividend:0.91

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)

Health Care Roundup: Market Talk

Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths

Fidia delays approval of half-year 2026 results to complete audit work

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday

MT Newswires Live

GPI Boosts Profitability and Foreign Growth on High-Margin Healthcare Software

Health Care Select Sector SPDR: Pivot points

Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812

Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

BeyondSpring announces U.S. FDA granted Fast Track designation to Plinabulin

SI-Bone (SIBN) Gets a Buy from Canaccord Genuity

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

CSPC Wins U.S. FDA Nod for Clinical Trials of Recombinant Shingles Vaccine

Nanjing King-Friend Subsidiary Secures FDA Interchangeability Approval for Adalimumab Drug

MT Newswires Live

Goldman Sachs Names 2 Undervalued Healthcare Stocks to Buy With At Least 50% Upside

Fortis, IHH to Cooperate With Court-Ordered Forensic Audit on 2018 Stake Deal

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":240.14,"timestamp":1791560849519,"preClose":223,"halted":0,"volume":363500,"delay":0,"changeRate":0.07686098654708515,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Trading","change":17.14,"latestTime":"10-09 11:47:38 EDT","open":223.71,"high":242.9359,"low":222.88,"amount":85568063.575,"amplitude":0.089937,"askPrice":241,"askSize":3,"bidPrice":240.23,"bidSize":130,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.003807,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.713593,"impliedVol":1.023,"impliedVolPercentile":0.8845},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.713593,"shares":2624500,"dividePrice":0.9143,"high":242.9359,"amplitude":0.089937,"preClose":223,"low":222.88,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":240.14,"committee":0.954887,"eps":0,"divideRate":0.003807,"volume":363500,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671743246","title":"Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671743246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671743246?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:40","pubTimestamp":1790700010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","XBI","XLV","HCSG","BK4585","NAMS","IVVD","BK4581","LU0128526141.USD","BK4539","BK4137","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246586","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246586?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:20","pubTimestamp":1790698800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671924571","title":"Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2671924571","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671924571?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:06","pubTimestamp":1790697960,"startTime":"0","endTime":"0","summary":"Neogen received warning letters from the Food and Drug Administration following an investigation that linked a vet wound care product labeled as sterile to serious infections and deaths in horses.The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4198","BK4585","LU2211817866.USD","NEOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248865","title":"Fidia delays approval of half-year 2026 results to complete audit work","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248865","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248865?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:03","pubTimestamp":1790690596,"startTime":"0","endTime":"0","summary":"Fidia Spa ( ($IT:FDA) ) just unveiled an update. Fidia S.p.A. has postponed the approval of its half-year financial report as of 30 June 2026, resc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidia-delays-approval-of-half-year-2026-results-to-complete-audit-work?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidia-delays-approval-of-half-year-2026-results-to-complete-audit-work?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217785","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671217785?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688638,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT) and Zymeworks (ZYME) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4588","XLV","LU2488822045.USD","XBI","BK4585","BK4139","SMMT","ZYME","LU0029874061.USD","LABU","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671176842","title":"Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2671176842","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671176842?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:24","pubTimestamp":1790688276,"startTime":"0","endTime":"0","summary":"Healthcare stocks were advancing pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  up 0.1% and the iShares Biotechnology ETF  0.3% higher.Iovance Biotherapeutics  stock was up more than 18% after the company raised its full year 2026 total revenue guidance to a range of $410 million to $420 million, from its prior outlook of $350 million to $370 million.UniQure  shares were down more than 47% after the company said additional data from its ongoing phase 1/2 studies of AMT-130 in Huntington's disease showed less pronounced benefits at 48 months.Pharming Group  has appointed chief commercial officer Leverne Marsh and chief financial officer Kenneth Lynard as interim co-chief executive officers, the company said. Pharming Group stock was down more than 3% pre-bell.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU0029874061.USD","BK4137","LABU","LU0320765992.SGD","IOVA","BK4585","LU0889565916.HKD","QURE","XLV","BK4139","PHAR","LU0128526141.USD","BK4581","HCSG","IBB","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671121562","title":"GPI Boosts Profitability and Foreign Growth on High-Margin Healthcare Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2671121562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671121562?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:53","pubTimestamp":1790686381,"startTime":"0","endTime":"0","summary":"GPI SpA ( ($IT:GPI) ) has shared an announcement. GPI SpA reported first-half 2026 revenues of €256.4 million, broadly stable year on year, as grow...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gpi-boosts-profitability-and-foreign-growth-on-high-margin-healthcare-software?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gpi-boosts-profitability-and-foreign-growth-on-high-margin-healthcare-software?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","LU0128526141.USD","XBI","BK4588","XLV","LABU","GPI","LU0029874061.USD","BK4581","HCSG","BK4214","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671231214","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2671231214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671231214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:38","pubTimestamp":1790685496,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.71, Pivot Low: $170.42. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-152?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-152?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219930","title":"Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219930?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:36","pubTimestamp":1790681804,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that a Type C meeting with the U.S. Food and Drug Administration, FDA, Division of Neurology has been sched...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4007","CGTX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268216","title":"Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268216","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268216?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680247,"startTime":"0","endTime":"0","summary":"Aldeyra (ALDX) Therapeutics announced intent to submit to the U.S. Food and Drug Administration a Formal Dispute Resolution Request for reproxalap,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aldeyra-to-submit-formal-dispute-resolution-request-to-fda-for-reproxalap-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aldeyra-to-submit-formal-dispute-resolution-request-to-fda-for-reproxalap-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","ALDX","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","REGN","LU2362541513.USD","LU0128526141.USD","LABU","BK4139","LU2023250504.SGD","SMMT","TBXU","LU2362540622.SGD","LU2089984988.USD","OCUL","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU2362541273.HKD","LU0289739699.SGD","BK4007","LU2106854487.HKD","XLV","BK4137","LU1974910355.USD","LU2488822045.USD","IBB","LU0029874061.USD","LU1917777945.USD","LU0109394709.USD","BBH","XBI","LU2237438978.USD","LU0114720955.EUR","BK4588","LU2468319806.SGD","HCSG","LU0823434740.USD","LU0882574055.USD","LU0058720904.USD","LU0823416689.USD","LU0053666078.USD","IBBQ","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216480","title":"BeyondSpring announces U.S. FDA granted Fast Track designation to Plinabulin","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216480","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216480?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679952,"startTime":"0","endTime":"0","summary":"BeyondSpring (BYSI) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation to Plinabulin and docetaxel for t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyondspring-announces-u-s-fda-granted-fast-track-designation-to-plinabulin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyondspring-announces-u-s-fda-granted-fast-track-designation-to-plinabulin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","LABU","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215009","title":"SI-Bone (SIBN) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215009?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:56","pubTimestamp":1790679373,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Caitlin Roberts reiterated a Buy rating on SI-Bone today and set a price target of $27.00. Roberts covers the Healthcare ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4082","LABU","BK4585","XBI","XLV","SIBN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671168852","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671168852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671168852?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679012,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF), Adagene (ADAG) and Inven...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2293690082.USD","BK4139","BK4585","BK4581","LU2539964713.USD","BK4588","LU0029874061.USD","HCSG","LABU","LU1046234339.USD","ADAG","BK4137","RHHVF","LU0128526141.USD","LU2293690249.USD","BK4007","XLV","XBI","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671568215","title":"Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671568215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671568215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:30","pubTimestamp":1790677819,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Quantum-Si (QSI) and Summit Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-abbvie-abbv-quantum-si-qsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-abbvie-abbv-quantum-si-qsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2125909247.SGD","LU0859254822.USD","LU0472753341.HKD","LU0726765562.USD","LU0029874061.USD","LU0868494708.USD","IE00B19Z3581.USD","AGNG","LU0203345920.USD","HCSG","MEDX","LU1989772923.USD","LU1670628061.USD","IXJ","ABBV","LU0942090050.USD","GLAM","LU0069063385.USD","QSI","JDOC","PPH","LU1720051017.SGD","TRUH","XLV","PJP","LU1267930490.SGD","IE00BJJMRZ35.SGD","LU1496350502.SGD","LU0823416689.USD","LU0432979614.USD","LU1037948897.HKD","SG9999015945.SGD","IYH","LU2023251221.USD","IE00BVYPNV92.GBP","RXL","SG9999015978.USD","FHLC","IE00BGHQF631.EUR","LU0234572021.USD","LU2237443978.SGD","LU0708994859.HKD","LU1983299246.USD","LU0689472784.USD","LABU","VHT","FTXH","XBI","LU0310800379.SGD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213104","title":"CSPC Wins U.S. FDA Nod for Clinical Trials of Recombinant Shingles Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213104","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213104?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:07","pubTimestamp":1790676469,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) just unveiled an update. CSPC Pharmaceutical Group has received U.S. Food and Drug Administration approval...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-wins-u-s-fda-nod-for-clinical-trials-of-recombinant-shingles-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-wins-u-s-fda-nod-for-clinical-trials-of-recombinant-shingles-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671946218","title":"Nanjing King-Friend Subsidiary Secures FDA Interchangeability Approval for Adalimumab Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2671946218","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671946218?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:53","pubTimestamp":1790675625,"startTime":"0","endTime":"0","summary":"Nanjing King-Friend Biochemical Pharmaceutical  subsidiary Emerge Bioscience received approval from the U.S. Food and Drug Administration for a Prior Approval Supplement or an interchangeability approval for its adalimumab injection, according to a Tuesday after-hours filing with the Shanghai bourse.The drug is indicated for pain relief from rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in patients 2 years and older, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, chronic plaque psoriasis, ulcerative colitis, hidradenitis suppurativa, and non-infectious uveitis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK4588","LABU","BK0186","BK4585","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213846","title":"Goldman Sachs Names 2 Undervalued Healthcare Stocks to Buy With At Least 50% Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213846?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:48","pubTimestamp":1790675280,"startTime":"0","endTime":"0","summary":"Investors have long had an interest in the healthcare sector. Some parts of it are considered recession-proof, while others bring in high returns. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/goldman-sachs-names-2-undervalued-healthcare-stocks-to-buy-with-at-least-50-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/goldman-sachs-names-2-undervalued-healthcare-stocks-to-buy-with-at-least-50-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1668664300.SGD","IE00B19Z3581.USD","LU0048573561.USD","GSX","IE0002270589.USD","LU1868836914.USD","LU2471134796.USD","LU2750360641.GBP","IXJ","XBI","XJUL","LU0251142724.SGD","XLV","NOBL","CGVV","CGDV","LU0210536198.USD","ASGM","LU2471134879.HKD","HCSG","CGCV","BK4588","LU2237443978.SGD","BK4516","LU2237443622.USD","TCAF","LU2471134523.USD","LU0096364046.USD","LU0868494617.USD","LU2237443465.HKD","BK4137","LU0742534661.SGD","STXV","OCTZ","GAPR","LU1868836591.USD","TCTL","LU1868836757.USD","VHT","LABU","LU2237443895.HKD","LU0128526141.USD","LU2265009873.SGD","LU2750360997.AUD","BK4550","IE00BFXG1179.USD","RULE","VTV","ABIG","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218452","title":"Fortis, IHH to Cooperate With Court-Ordered Forensic Audit on 2018 Stake Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218452?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:44","pubTimestamp":1790675099,"startTime":"0","endTime":"0","summary":"Fortis Healthcare Ltd. ( ($IN:FORTIS) ) has shared an update. Fortis Healthcare has disclosed that the Supreme Court of India has disposed of its S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-to-cooperate-with-court-ordered-forensic-audit-on-2018-stake-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-to-cooperate-with-court-ordered-forensic-audit-on-2018-stake-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4585","XBI","LABU","MNDmain","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218310","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218310","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218310?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:41","pubTimestamp":1790674860,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370567/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","HCSG","XBI","BK4585","LU0128526141.USD","BK4137","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":17,"totalSize":424,"code":"91000000","status":"200"}]}}